128 related articles for article (PubMed ID: 34061870)
1. Prevalence of elevated liver transaminases and their relationship with alcohol use in people living with HIV on anti-retroviral therapy in Uganda.
Freiman JM; Fatch R; Cheng D; Emenyonu N; Ngabirano C; Geadas C; Adong J; Muyindike WR; Linas BP; Jacobson KR; Hahn JA
PLoS One; 2021; 16(6):e0250368. PubMed ID: 34061870
[TBL] [Abstract][Full Text] [Related]
2. Hepatotoxicity During Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living With HIV With Severe Immunosuppression: A Secondary Analysis of a Multi-Country Open-Label Randomized Controlled Clinical Trial.
Ngongondo M; Miyahara S; Hughes MD; Sun X; Bisson GP; Gupta A; Kumwenda J; Lavenberg JA; Torres TS; Nyirenda M; Kidonge KK; Hosseinipour MC;
J Acquir Immune Defic Syndr; 2018 May; 78(1):54-61. PubMed ID: 29406428
[TBL] [Abstract][Full Text] [Related]
3. Tuberculin skin test positivity among HIV-infected alcohol drinkers on antiretrovirals in south-western Uganda.
Muyindike WR; Fatch R; Cheng DM; Emenyonu NI; Ngabirano C; Adong J; Linas BP; Jacobson KR; Hahn JA
PLoS One; 2020; 15(7):e0235261. PubMed ID: 32614873
[TBL] [Abstract][Full Text] [Related]
4. Strategies for isoniazid preventive therapy in HIV-positive patients who consume alcohol.
Savinkina A; Muyindike W; Hahn JA; Emenyonu NI; Fatch R; Ngabirano C; Adong J; Jacobson KR; Linas BP
Int J Tuberc Lung Dis; 2024 Jul; 28(7):335-342. PubMed ID: 38961548
[TBL] [Abstract][Full Text] [Related]
5. Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit Analysis.
Freiman JM; Jacobson KR; Muyindike WR; Horsburgh CR; Ellner JJ; Hahn JA; Linas BP
J Acquir Immune Defic Syndr; 2018 Apr; 77(4):405-412. PubMed ID: 29239900
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of isoniazid preventive therapy for tuberculosis for persons with HIV with and without alcohol use.
Hahn JA; Ngabirano C; Fatch R; Emenyonu NI; Cheng DM; Adong J; Tumwegamire A; Terrault NA; Linas BP; Jacobson KR; Muyindike WR
AIDS; 2023 Aug; 37(10):1535-1543. PubMed ID: 37260251
[TBL] [Abstract][Full Text] [Related]
7. Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana.
Tedla Z; Nyirenda S; Peeler C; Agizew T; Sibanda T; Motsamai O; Vernon A; Wells CD; Samandari T
Am J Respir Crit Care Med; 2010 Jul; 182(2):278-85. PubMed ID: 20378730
[TBL] [Abstract][Full Text] [Related]
8. Determinants of alcohol use among people living with HIV initiating isoniazid preventive therapy in Ethiopia.
Mukherjee TI; Hirsch-Moverman Y; Saito S; Gadisa T; Melaku Z; Howard AA
Drug Alcohol Depend; 2019 Nov; 204():107465. PubMed ID: 31499239
[TBL] [Abstract][Full Text] [Related]
9. Liver enzymes improve over twenty-four months of first-line non-nucleoside reverse transcriptase inhibitor-based therapy in rural Uganda.
Weidle PJ; Moore D; Mermin J; Buchacz K; Were W; Downing R; Kigozi A; Ndazima V; Peters P; Brooks JT
AIDS Patient Care STDS; 2008 Oct; 22(10):787-95. PubMed ID: 18778241
[TBL] [Abstract][Full Text] [Related]
10. A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.
Sensalire S; Karungi Karamagi Nkolo E; Nabwire J; Lawino A; Kiragga D; Muhire M; Kadama H; Katureebe C; Namuwenge P; Musinguzi J; Calnan J; Seyoum D
AIDS Res Ther; 2020 May; 17(1):28. PubMed ID: 32460788
[TBL] [Abstract][Full Text] [Related]
11. Alcohol Interactive Toxicity Beliefs and ART Non-adherence Among HIV-Infected Current Drinkers in Mbarara, Uganda.
Fatch R; Emenyonu NI; Muyindike W; Kekibiina A; Woolf-King S; Hahn JA
AIDS Behav; 2017 Jul; 21(7):1812-1824. PubMed ID: 27198557
[TBL] [Abstract][Full Text] [Related]
12. Alcohol consumption increases non-adherence to ART among people living with HIV enrolled to the community-based care model in rural northern Uganda.
Adrawa N; Alege JB; Izudi J
PLoS One; 2020; 15(11):e0242801. PubMed ID: 33232369
[TBL] [Abstract][Full Text] [Related]
13. Post-traumatic stress disorder among persons with HIV who engage in heavy alcohol consumption in southwestern Uganda.
Kekibiina A; Adong J; Fatch R; Emenyonu NI; Marson K; Beesiga B; Lodi S; Muyindike WR; Kamya M; Chamie G; McDonell MG; Hahn JA
BMC Psychiatry; 2021 Sep; 21(1):457. PubMed ID: 34535103
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and incidence of hypertension in a heavily treatment-experienced cohort of people living with HIV in Uganda.
Byonanebye DM; Polizzotto MN; Parkes-Ratanshi R; Musaazi J; Petoumenos K; Castelnuovo B
PLoS One; 2023; 18(2):e0282001. PubMed ID: 36800379
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
Kovari H; Ledergerber B; Battegay M; Rauch A; Hirschel B; Foguena AK; Vernazza P; Bernasconi E; Mueller NJ; Weber R
Clin Infect Dis; 2010 Feb; 50(4):502-11. PubMed ID: 20085465
[TBL] [Abstract][Full Text] [Related]
16. Self-reported alcohol abstinence associated with ART initiation among HIV-infected persons in rural Uganda.
Santos GM; Emenyonu NI; Bajunirwe F; Rain Mocello A; Martin JN; Vittinghoff E; Bangsberg DR; Hahn JA
Drug Alcohol Depend; 2014 Jan; 134():151-157. PubMed ID: 24169501
[TBL] [Abstract][Full Text] [Related]
17. Assessing the interaction between depressive symptoms and alcohol use prior to antiretroviral therapy on viral suppression among people living with HIV in Rural Uganda.
Foley JD; Sheinfil A; Woolf-King SE; Fatch R; Emenyonu NI; Muyindike WR; Kekibiina A; Ngabirano C; Samet JH; Cheng DM; Hahn JA
AIDS Care; 2020 Oct; 32(10):1251-1257. PubMed ID: 32482097
[TBL] [Abstract][Full Text] [Related]
18. Transaminitis prevalence among HIV-infected adults eligible for tuberculosis preventive therapy.
Chaisson LH; Semitala FC; Mwebe S; Katende J; Asege L; Nakaye M; Andama AO; Atuhumuza E; Kamya M; Cattamanchi A; Yoon C
AIDS; 2022 Sep; 36(11):1591-1595. PubMed ID: 35730395
[TBL] [Abstract][Full Text] [Related]
19. Predictors of isoniazid preventive therapy completion among HIV-infected patients receiving differentiated and non-differentiated HIV care in rural Uganda.
Tram KH; Mwangwa F; Chamie G; Atukunda M; Owaraganise A; Ayieko J; Jain V; Clark TD; Kwarisiima D; Petersen ML; Kamya MR; Charlebois ED; Havlir DV; Marquez C;
AIDS Care; 2020 Jan; 32(1):119-127. PubMed ID: 31181961
[TBL] [Abstract][Full Text] [Related]
20. Nonviral Liver Disease Burden in People Living With HIV and Elevated Transaminases: A Cross-Sectional Study.
Katarey D; Tan Y; Mourad A; Potts JR; Vickers L; Beksinska A; Sharp H; Parnell B; Gilleece Y; Verma S
J Acquir Immune Defic Syndr; 2024 Jan; 95(1):97-106. PubMed ID: 37831608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
